1.

2.
Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide
by Muzzi, Alessandro
Vaccine, 2019-02-08, Vol.37 (7), p.991-1000

3.
Social differentiation of vaccine hesitancy among French parents and the mediating role of trust and commitment to health: A nationwide cross-sectional study
by Bocquier, Aurélie
Vaccine, 2018-11-29, Vol.36 (50), p.7666-7673

4.
Vaccine hesitancy and self-vaccination behaviors among nurses in southeastern France
by Wilson, Rose
Vaccine, 2020-01-29, Vol.38 (5), p.1144-1151

5.
Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?
by Hong, Eva
Vaccine, 2012, Vol.31 (7), p.1113-1116

6.
Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice
by Wen, Yingxia
Vaccine, 2014, Vol.32 (30), p.3796-3804

7.
Emergence of serogroup X meningococcal disease in Africa: Need for a vaccine
by Xie, Ouli
Vaccine, 2013, Vol.31 (27), p.2852-2861

8.
A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials
by Boge, Thierry
Vaccine, 2009, Vol.27 (41), p.5677-5684

9.
Vaccine-criticism on the internet: New insights based on French-speaking websites
by Ward, Jeremy K
Vaccine, 2014, Vol.33 (8), p.1063-1070

10.
Role of antigen specific T and B cells in systemic and mucosal immune responses in ETEC and Shigella infections, and their potential to serve as correlates of protection in vaccine...
by Mani, Sachin
Vaccine, 2019-08-07, Vol.37 (34), p.4787-4793

11.
Estimation of parameters related to vaccine efficacy and dengue transmission from two large phase III studies
by Coudeville, Laurent
Vaccine, 2015, Vol.34 (50), p.6417-6425

12.
Effectiveness of an intervention campaign on influenza vaccination of professionals in nursing homes: A cluster-randomized controlled trial
by Borgey, France
Vaccine, 2019-02-28, Vol.37 (10), p.1260-1265

13.
Purification of rabies virus produced in Vero cells grown in serum free medium
by Trabelsi, Khaled
Vaccine, 2019-11-08, Vol.37 (47), p.7052-7060

14.
Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine
by Demeure, Christian E
Vaccine, 2019-01-03, Vol.37 (1), p.123-129

15.
Barriers to timely administration of birth dose vaccines in The Gambia, West Africa
by Miyahara, Reiko
Vaccine, 2016, Vol.34 (29), p.3335-3341

16.
Subcutaneous vaccination with a live attenuated Yersinia pseudotuberculosis plague vaccine
by Derbise, Anne
Vaccine, 2020-02-18, Vol.38 (8), p.1888-1892

17.
Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system
by Bottai, Daria
Vaccine, 2015, Vol.33 (23), p.2710-2718

18.
Meningococcal disease in the Asia-Pacific region: Findings and recommendations from the Global Meningococcal Initiative
by Borrow, Ray
Vaccine, 2016, Vol.34 (48), p.5855-5862

19.
Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge
by Schutta, Christopher
Vaccine, 2016, Vol.34 (27), p.3214-3220

20.
Image of the new vaccination obligation through the media
by Mitilian, Eva
Vaccine, 2020-01-16, Vol.38 (3), p.498-511
